Ubellacker, Jessalyn M.

CDK4/6 inhibition triggers anti-tumour immunity

Goel, S., DeCristo, M. J., Watt, A. C., BrinJones, H., Sceneay, J., Li, B. B., Khan, N., Ubellacker, J. M., Xie, S., Metzger-Filho, O., et al. (2017) · Nature

Cancer Immunotherapy and BiomarkersAdvanced Breast Cancer Therapies

Cited by 1,513

Metabolic heterogeneity confers differences in melanoma metastatic potential

Tasdogan, A., Faubert, B., Ramesh, V., Ubellacker, J. M., Shen, B., Solmonson, A., Murphy, M. M., Gu, Z., Gu, W., Martin, M., et al. (2020) · Nature

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

Cited by 509

Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA

Islam, M. A., Xu, Y., Tao, W., Ubellacker, J. M., Lim, M., Aum, D., Lee, G. Y., Zhou, K., Zope, H., Yu, M., et al. (2018) · Nature Biomedical Engineering

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 339

A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis

Shen, B., Tasdogan, A., Ubellacker, J. M., Zhang, J., Nosyreva, E. D., Du, L., Murphy, M. M., Hu, S., Yi, Y., Kara, N., et al. (2021) · Nature

Bone Metabolism and DiseasesHematopoietic Stem Cell Transplantation

Cited by 310

Activation of lysosomal iron triggers ferroptosis in cancer

Cañeque, T., Baron, L., Müller, S., Carmona, A., Colombeau, L., Versini, A., Solier, S., Gaillet, C., Sindikubwabo, F., Sampaio, J. L., et al. (2025) · Nature

Ferroptosis and cancer prognosisIron Metabolism and Disorders

Cited by 287

Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer

Sceneay, J., Goreczny, G. J., Wilson, K., Morrow, S., DeCristo, M. J., Ubellacker, J. M., Qin, Y., Laszewski, T., Stover, D. G., Barrera, V., et al. (2019) · Cancer Discovery

Cancer Immunotherapy and Biomarkersinterferon and immune responses

Cited by 156